Literature DB >> 26478751

Estimation After a Group Sequential Trial.

Elasma Milanzi1, Geert Molenberghs2, Ariel Alonso3, Michael G Kenward4, Anastasios A Tsiatis5, Marie Davidian5, Geert Verbeke6.   

Abstract

Group sequential trials are one important instance of studies for which the sample size is not fixed a priori but rather takes one of a finite set of pre-specified values, dependent on the observed data. Much work has been devoted to the inferential consequences of this design feature. Molenberghs et al (2012) and Milanzi et al (2012) reviewed and extended the existing literature, focusing on a collection of seemingly disparate, but related, settings, namely completely random sample sizes, group sequential studies with deterministic and random stopping rules, incomplete data, and random cluster sizes. They showed that the ordinary sample average is a viable option for estimation following a group sequential trial, for a wide class of stopping rules and for random outcomes with a distribution in the exponential family. Their results are somewhat surprising in the sense that the sample average is not optimal, and further, there does not exist an optimal, or even, unbiased linear estimator. However, the sample average is asymptotically unbiased, both conditionally upon the observed sample size as well as marginalized over it. By exploiting ignorability they showed that the sample average is the conventional maximum likelihood estimator. They also showed that a conditional maximum likelihood estimator is finite sample unbiased, but is less efficient than the sample average and has the larger mean squared error. Asymptotically, the sample average and the conditional maximum likelihood estimator are equivalent. This previous work is restricted, however, to the situation in which the the random sample size can take only two values, N = n or N = 2n. In this paper, we consider the more practically useful setting of sample sizes in a the finite set {n1, n2, …, nL }. It is shown that the sample average is then a justifiable estimator , in the sense that it follows from joint likelihood estimation, and it is consistent and asymptotically unbiased. We also show why simulations can give the false impression of bias in the sample average when considered conditional upon the sample size. The consequence is that no corrections need to be made to estimators following sequential trials. When small-sample bias is of concern, the conditional likelihood estimator provides a relatively straightforward modification to the sample average. Finally, it is shown that classical likelihood-based standard errors and confidence intervals can be applied, obviating the need for technical corrections.

Entities:  

Keywords:  Exponential Family; Frequentist Inference; Generalized Sample Average; Joint Modeling; Likelihood Inference; Missing at Random; Sample Average

Year:  2014        PMID: 26478751      PMCID: PMC4603757          DOI: 10.1007/s12561-014-9112-6

Source DB:  PubMed          Journal:  Stat Biosci        ISSN: 1867-1764


  6 in total

Review 1.  A unified theory for sequential clinical trials.

Authors:  J Whitehead
Journal:  Stat Med       Date:  1999 Sep 15-30       Impact factor: 2.373

Review 2.  Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis.

Authors:  Dirk Bassler; Matthias Briel; Victor M Montori; Melanie Lane; Paul Glasziou; Qi Zhou; Diane Heels-Ansdell; Stephen D Walter; Gordon H Guyatt; David N Flynn; Mohamed B Elamin; Mohammad Hassan Murad; Nisrin O Abu Elnour; Julianna F Lampropulos; Amit Sood; Rebecca J Mullan; Patricia J Erwin; Clare R Bankhead; Rafael Perera; Carolina Ruiz Culebro; John J You; Sohail M Mulla; Jagdeep Kaur; Kara A Nerenberg; Holger Schünemann; Deborah J Cook; Kristina Lutz; Christine M Ribic; Noah Vale; German Malaga; Elie A Akl; Ignacio Ferreira-Gonzalez; Pablo Alonso-Coello; Gerard Urrutia; Regina Kunz; Heiner C Bucher; Alain J Nordmann; Heike Raatz; Suzana Alves da Silva; Fabio Tuche; Brigitte Strahm; Benjamin Djulbegovic; Neill K J Adhikari; Edward J Mills; Femida Gwadry-Sridhar; Haresh Kirpalani; Heloisa P Soares; Paul J Karanicolas; Karen E A Burns; Per Olav Vandvik; Fernando Coto-Yglesias; Pedro Paulo M Chrispim; Tim Ramsay
Journal:  JAMA       Date:  2010-03-24       Impact factor: 56.272

3.  Stopping rules and estimation problems in clinical trials.

Authors:  M D Hughes; S J Pocock
Journal:  Stat Med       Date:  1988-12       Impact factor: 2.373

4.  Exact confidence intervals following a group sequential test.

Authors:  A A Tsiatis; G L Rosner; C R Mehta
Journal:  Biometrics       Date:  1984-09       Impact factor: 2.571

5.  Properties of Estimators in Exponential Family Settings with Observation-based Stopping Rules.

Authors:  Elasma Milanzi; Geert Molenberghs; Ariel Alonso; Michael G Kenward; Geert Verbeke; Anastasios A Tsiatis; Marie Davidian
Journal:  J Biom Biostat       Date:  2016-01-25

6.  On random sample size, ignorability, ancillarity, completeness, separability, and degeneracy: sequential trials, random sample sizes, and missing data.

Authors:  Geert Molenberghs; Michael G Kenward; Marc Aerts; Geert Verbeke; Anastasios A Tsiatis; Marie Davidian; Dimitris Rizopoulos
Journal:  Stat Methods Med Res       Date:  2012-04-18       Impact factor: 3.021

  6 in total
  1 in total

Review 1.  An Investigation of the Shortcomings of the CONSORT 2010 Statement for the Reporting of Group Sequential Randomised Controlled Trials: A Methodological Systematic Review.

Authors:  Abigail Stevely; Munyaradzi Dimairo; Susan Todd; Steven A Julious; Jonathan Nicholl; Daniel Hind; Cindy L Cooper
Journal:  PLoS One       Date:  2015-11-03       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.